Balance Sheet Laboratorios Richmond S.A.C.I.F.

Stocks

RICH

ARLRIC300027

Pharmaceuticals

End-of-day quote Buenos Aires S.E. Other stock markets 2026-07-06			5-day change	1st Jan Change
1,540.00 ^ARS	-2.84%		-1.91%	-22.03%

05-10	Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026	CI
05-07	Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

9ec65.pOK9XEhjyy291l1j_Qj7DGN_1ZP-8waFi0Tul-cjEEs.7K7NJH07-Ufc4gVUzm-pZFI1geGfwWnkyg-4_YQQRwfWitgtBQKzWeywHA

Published financial data: LABORATORIOS RICHMOND S.A.C.I.F.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	16.62B	18.47B	39.03B	91.79B	127B
Total Revenues	16.62B	18.47B	39.03B	91.79B	127B
Cost of Goods Sold, Total	11.58B	9.61B	18.72B	41.56B	48.27B
Gross Profit	5.04B	8.86B	20.31B	50.24B	78.45B
Selling General & Admin Expenses, Total	2.52B	5.53B	15.01B	32.97B	46.83B
Other Operating Expenses	192M	347M	-	1.7B	1.71B
Other Operating Expenses, Total	2.72B	5.88B	15.01B	34.67B	48.55B
Operating Income	2.32B	2.98B	5.3B	15.57B	29.91B
Interest Expense, Total	-745M	-1.43B	-5.31B	-3.29B	-14.97B
Interest And Investment Income	-	-	-	7.2B	-
Net Interest Expenses	-745M	-1.43B	-5.31B	3.92B	-14.97B
Income (Loss) On Equity Invest.	-	2.35M	-3.85M	-381M	-63.36M
Currency Exchange Gains (Loss)	-915M	-2.94B	-25.29B	-8.73B	-13.05B
Other Non Operating Income (Expenses)	31.32M	1.87B	14.9B	20.61B	13.42B
EBT, Excl. Unusual Items	693M	484M	-10.4B	30.98B	15.25B
Impairment of Goodwill	-	-	-241M	-1.83B	-
Gain (Loss) On Sale Of Investments	737M	327M	-3.28B	-	-6.91B
Gain (Loss) On Sale Of Assets	3.32M	2.63M	-	-	-
Legal Settlements	-16.5M	-14.37M	-	-574M	-229M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	1.42B	799M	-13.92B	28.58B	8.1B
Income Tax Expense	816M	640M	-3B	4.77B	5.97B
Earnings From Continuing Operations	601M	159M	-10.93B	23.81B	2.14B
Earnings Of Discontinued Operations	-	-	-	-	684M
Net Income to Company	601M	159M	-10.93B	23.81B	2.82B
Minority Interest	-9.97M	4.04M	75.55M	33.7M	265M
Net Income - (IS)	591M	163M	-10.85B	23.85B	3.09B
Net Income to Common Incl Extra Items	591M	163M	-10.85B	23.85B	3.09B
Net Income to Common Excl. Extra Items	591M	163M	-10.85B	23.85B	2.4B
Per Share Items
Net EPS - Basic	7.32	2.02	-134.37	295.29	38.24
Basic EPS - Continuing Operations	7.32	2.02	-134.37	295.29	29.77
Basic Weighted Average Shares Outstanding	80.8M	80.91M	80.75M	80.75M	80.75M
Net EPS - Diluted	7.32	2.02	-134.37	295.29	38.24
Diluted EPS - Continuing Operations	7.32	2.02	-134.37	295.29	29.77
Diluted Weighted Average Shares Outstanding	80.8M	80.91M	80.75M	80.75M	80.75M
Normalized Basic EPS	5.24	3.79	-79.57	240.21	121.28
Normalized Diluted EPS	5.24	3.79	-79.57	240.21	121.28
Dividend Per Share	-	-	-	26.89	-
Payout Ratio	10.12	311.3	-	-	85.2
Supplemental Items
EBITDA	2.49B	3.33B	6.44B	18.25B	33B
EBITA	2.32B	2.98B	5.3B	15.57B	29.91B
EBIT	2.32B	2.98B	5.3B	15.57B	29.91B
EBITDAR	2.49B	-	-	-	-
Effective Tax Rate - (Ratio)	57.57	80.06	21.53	16.68	73.6
Normalized Net Income	423M	307M	-6.43B	19.4B	9.79B
Interest on Long-Term Debt	-	9.07M	24.12M	33.4M	64.77M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	46.55M	88.43M	231M	-	-
Selling and Marketing Expenses	1.79B	4.25B	11.12B	24.76B	35.51B
General and Administrative Expenses	736M	1.28B	3.89B	8.22B	11.32B
Research And Development Expense From Footnotes	141M	314M	4.79B	3.63B	6.33B
Net Rental Expense, Total	332K	-	-	-	-
Imputed Operating Lease Interest Expense	281K	-	-	-	-
Imputed Operating Lease Depreciation	51.24K	-	-	-	-
Maintenance & Repair Expenses, Total	-	-	598M	1B	1.28B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.67B	1.26B	637M	7.02B	10.85B
Short Term Investments	2.5B	1.3B	186M	2.95B	4.5B
Total Cash And Short Term Investments	7.17B	2.55B	823M	9.97B	15.35B
Accounts Receivable, Total	3.53B	4.76B	11.28B	28.17B	58.56B
Other Receivables	465M	1.02B	2.55B	3.86B	4.17B
Notes Receivable	7.06M	332K	616K	-	-
Total Receivables	4B	5.78B	13.83B	32.03B	62.73B
Inventory	3.82B	5.18B	15.8B	25.39B	41.67B
Other Current Assets, Total	437M	531M	950M	1.24B	794M
Total Current Assets	15.43B	14.04B	31.4B	68.62B	121B
Gross Property Plant And Equipment	9.54B	25.08B	112B	184B	283B
Accumulated Depreciation	-1.56B	-3.29B	-11.01B	-25.52B	-37.06B
Net Property Plant And Equipment	7.98B	21.79B	101B	159B	246B
Long-term Investments	27.9M	226M	1.17B	1.17B	2.03B
Goodwill	531M	1.02B	2.75B	4.16B	5.69B
Other Intangibles, Total	7.96M	74.57M	557M	340M	554M
Deferred Tax Assets Long-Term	137M	198M	5.28B	909M	2.24B
Deferred Charges Long-Term	1.45B	3.26B	12.19B	25.74B	41.4B
Other Long-Term Assets, Total	123M	109M	554M	679M	1.58B
Total Assets	25.69B	40.72B	155B	260B	420B
Liabilities
Accounts Payable, Total	5.72B	4.79B	23.75B	28.54B	43.85B
Accrued Expenses, Total	1.46B	1.16B	2.69B	8.41B	12.22B
Short-term Borrowings	65.31M	46.72M	637M	723M	2.81B
Current Portion of Long-Term Debt	1.72B	2.81B	8.9B	17.56B	56.52B
Current Portion of Leases	37.78M	53.15M	125M	296M	473M
Current Income Taxes Payable	49.25M	333K	-	769M	2.17B
Other Current Liabilities	265M	172M	204M	536M	1.76B
Total Current Liabilities	9.33B	9.03B	36.31B	56.84B	120B
Long-Term Debt	9.55B	18.4B	84.16B	125B	166B
Long-Term Leases	108M	137M	324M	-	20.21B
Deferred Tax Liability Non Current	1.32B	2.9B	11.08B	12.87B	20.83B
Other Non Current Liabilities	12.3M	27.64M	80.54M	61.74M	57.84M
Total Liabilities	20.32B	30.5B	132B	195B	327B
Preferred Stock Non Redeemable	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	80.75M	80.75M	80.75M	80.75M	80.75M
Additional Paid In Capital	2.29B	4.47B	13.92B	30.31B	39.88B
Retained Earnings	1.28B	2.44B	-3.27B	16.75B	22.68B
Comprehensive Income and Other	1.64B	3.1B	11.82B	17.15B	28.86B
Total Common Equity	5.29B	10.09B	22.55B	64.3B	91.5B
Minority Interest	82.01M	127M	403M	1.05B	1.54B
Total Equity	5.38B	10.22B	22.95B	65.35B	93.04B
Total Liabilities And Equity	25.69B	40.72B	155B	260B	420B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	80.75M	80.75M	80.75M	80.75M	80.75M
ECS Total Common Shares Outstanding	80.75M	80.75M	80.75M	80.75M	80.75M
Book Value / Share	65.55	124.95	279.25	796.24	1.13K
Tangible Book Value	4.75B	9B	19.24B	59.8B	85.25B
Tangible Book Value Per Share	58.88	111.43	238.31	740.52	1.06K
Total Debt	11.48B	21.45B	94.15B	144B	246B
Net Debt	4.32B	18.9B	93.33B	134B	231B
Debt Equivalent Oper. Leases	2.65M	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	82.01M	127M	403M	1.05B	1.54B
Equity Method Investments, Total	-	-	344M	58.59M	174M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	834M	1.79B	5.45B	12.77B	18.74B
Inventories - Work In Process, Total	351M	296M	1.46B	3.98B	6.03B
Inventories - Finished Goods, Total	2.92B	3.49B	10.1B	11.62B	20.24B
Land - (BS)	896M	1.88B	6.5B	7.73B	16.3B
Machinery, Total	1.79B	3.76B	12.94B	27.44B	169B
Full Time Employees	620	620	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	51.93M	79.69M	214M	359M	702M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	591M	163M	-10.85B	23.85B	3.09B
Depreciation & Amortization - CF	203M	414M	1.28B	2.75B	4.02B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	4.64M
Depreciation & Amortization, Total	203M	414M	1.28B	2.75B	4.02B
Amortization of Deferred Charges, Total - (CF)	143M	317M	1.06B	4.53B	6.55B
Minority Interest in Earnings - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	1.35M	1.05M	281M	1.88B	235M
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-2.35M	-	-	-
Provision and Write-off of Bad Debts	16.54M	56.19M	-22.19M	136M	210M
Other Operating Activities, Total	1.07B	-851M	-16.54B	-11.76B	-4.19B
Change In Accounts Receivable	-685M	-1.45B	-4.49B	-18.57B	-24.96B
Change In Inventories	-1.58B	2.41B	271M	8.58B	-7.65B
Change In Accounts Payable	3.26B	-3.89B	25.97B	-7.26B	14.88B
Change In Income Taxes	25.43M	-177M	-69.1M	1.45B	-1.49B
Change in Other Net Operating Assets	688M	-1.27B	609M	32.43M	11.18B
Cash from Operations	3.73B	-4.29B	-2.51B	5.62B	1.87B
Capital Expenditure	-5.3B	-6.69B	-9.4B	-4.72B	-37.79B
Sale of Property, Plant, and Equipment	-	-	-	-	3.72B
Cash Acquisitions	-9.43M	-	-	-	-
Divestitures	-	-	-	150M	326M
Sale (Purchase) of Intangible assets	-631M	-831M	-3.11B	-4.08B	-16.54B
Investment in Marketable and Equity Securities, Total	-127M	57.87M	-455M	-285M	-741M
Other Investing Activities, Total	19.37M	17.29M	419M	-	-
Cash from Investing	-6.05B	-7.44B	-12.55B	-8.95B	-51.03B
Long-Term Debt Issued, Total	9.19B	1.82B	9.25B	12.46B	57.18B
Total Debt Issued	9.19B	1.82B	9.25B	12.46B	57.18B
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-59.87M	-509M	-	-	-2.63B
Common & Preferred Stock Dividends Paid	-59.87M	-509M	-	-	-2.63B
Cash from Financing	9.13B	1.31B	9.25B	12.46B	54.55B
Miscellaneous Cash Flow Adjustments	-259M	-1.23B	-1.74B	-969M	-3.14B
Net Change in Cash	6.56B	-11.65B	-7.55B	8.17B	2.24B
Supplemental Items
Levered Free Cash Flow	-2.23B	-9.69B	2.58B	-5.69B	-52.8B
Unlevered Free Cash Flow	-1.76B	-8.8B	5.9B	-3.63B	-43.44B
Change In Net Working Capital	-2.37B	3.87B	-12.77B	11.82B	18.37B
Net Debt Issued / Repaid	9.19B	1.82B	9.25B	12.46B	57.18B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.51	4.11	2.35	3.26	4.9
Return on Total Capital	11.77	5.78	3.07	4.19	6.09
Return On Equity %	11.37	1.54	-39.9	41.29	2.39
Return on Common Equity	11.38	1.6	-40.21	42.05	2.73
Margin Analysis
Gross Profit Margin %	30.33	47.97	52.04	54.73	61.91
SG&A Margin	15.19	29.94	38.46	35.92	36.96
EBITDA Margin %	14.96	18.01	16.5	19.88	26.04
EBITA Margin %	13.98	16.15	13.58	16.96	23.6
EBIT Margin %	13.98	16.15	13.58	16.96	23.6
Income From Continuing Operations Margin %	3.62	0.86	-28	25.94	1.69
Net Income Margin %	3.56	0.88	-27.8	25.98	2.44
Net Avail. For Common Margin %	3.56	0.88	-27.8	25.98	1.9
Normalized Net Income Margin	2.55	1.66	-16.46	21.13	7.73
Levered Free Cash Flow Margin	-13.41	-52.46	6.61	-6.19	-41.66
Unlevered Free Cash Flow Margin	-10.61	-47.62	15.11	-3.96	-34.28
Asset Turnover
Asset Turnover	0.86	0.41	0.28	0.31	0.33
Fixed Assets Turnover	3.02	0.99	0.46	0.49	0.56
Receivables Turnover (Average Receivables)	4.24	3.17	2.99	3.48	2.65
Inventory Turnover (Average Inventory)	3.7	1.52	1.17	1.39	1.29
Short Term Liquidity
Current Ratio	1.66	1.55	0.86	1.21	1.01
Quick Ratio	1.2	0.92	0.4	0.74	0.65
Operating Cash Flow to Current Liabilities	0.4	-0.47	-0.07	0.1	0.02
Days Sales Outstanding (Average Receivables)	86.14	114.98	121.97	105.11	137.7
Days Outstanding Inventory (Average Inventory)	98.55	239.77	311.17	263.26	283.78
Average Days Payable Outstanding	130.63	396.42	383.54	451.29	262.73
Cash Conversion Cycle (Average Days)	54.05	-41.66	49.61	-82.92	158.75
Long Term Solvency
Total Debt/Equity	213.63	209.94	410.21	219.76	264.82
Total Debt / Total Capital	68.12	67.74	80.4	68.73	72.59
LT Debt/Equity	179.67	181.45	368.1	191.34	200.54
Long-Term Debt / Total Capital	57.29	58.54	72.15	59.84	54.97
Total Liabilities / Total Assets	79.08	74.91	85.18	74.88	77.86
EBIT / Interest Expense	3.12	2.08	1	4.73	2
EBITDA / Interest Expense	3.39	2.37	1.24	5.57	2.27
(EBITDA - Capex) / Interest Expense	-3.72	-2.3	-0.53	4.13	-0.26
Total Debt / EBITDA	4.55	6.31	14.31	7.84	7.26
Net Debt / EBITDA	1.71	5.56	14.19	7.3	6.81
Total Debt / (EBITDA - Capex)	-4.14	-6.52	-33.31	10.57	-63.83
Net Debt / (EBITDA - Capex)	-1.56	-5.74	-33.02	9.84	-59.86
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	78.08	-42.93	-32.15	8.01	4.95
Gross Profit, 1 Yr. Growth %	10.82	-7.73	-25.27	12.24	19.22
EBITDA, 1 Yr. Growth %	-3.79	-35.6	-44.09	9.8	11.98
EBITA, 1 Yr. Growth %	-2.79	-37.48	-48.21	12.49	15.69
EBIT, 1 Yr. Growth %	-0.26	-33.6	-42.67	34.89	50.28
Earnings From Cont. Operations, 1 Yr. Growth %	-18.01	-86.39	-2.3K	-200.07	-93.17
Net Income, 1 Yr. Growth %	-19.41	-85.81	-2.23K	-200.91	-90.16
Normalized Net Income, 1 Yr. Growth %	-41.35	-61.91	-793.41	-205.05	-33.84
Diluted EPS Before Extra, 1 Yr. Growth %	-19.47	-85.84	-2.23K	-200.91	-92.34
Accounts Receivable, 1 Yr. Growth %	-18.03	-30.89	-23.87	14.73	58.03
Inventory, 1 Yr. Growth %	57.61	-30.52	-2.01	-26.19	24.76
Net Property, Plant and Equip., 1 Yr. Growth %	162.24	40.27	48.82	-27.92	18.08
Total Assets, 1 Yr. Growth %	98.6	-18.64	22.16	-22.88	22.81
Tangible Book Value, 1 Yr. Growth %	4.74	-2.84	-31.32	42.7	8.37
Common Equity, 1 Yr. Growth %	3.74	-2.15	-28.24	30.94	8.17
Cash From Operations, 1 Yr. Growth %	-2.16K	-158.92	-81.22	-223.73	-74.77
Capital Expenditures, 1 Yr. Growth %	843.51	-35.18	-54.85	-76.93	507.97
Levered Free Cash Flow, 1 Yr. Growth %	68.6	32.15	-107.73	-69.31	291.89
Unlevered Free Cash Flow, 1 Yr. Growth %	75.34	36.89	-119.29	-46.82	454.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	77.01	40.7	9.81	26.33	22.11
Gross Profit, 2 Yr. CAGR %	39.9	39.59	45.44	35.96	32.4
EBITDA, 2 Yr. CAGR %	41.07	13.47	11.68	25.85	40.91
EBITA, 2 Yr. CAGR %	45.09	11.73	5.4	23.34	47.02
EBIT, 2 Yr. CAGR %	47.82	13.17	8.61	29.77	60.99
Earnings From Cont. Operations, 2 Yr. CAGR %	87.57	-53.38	205.39	592.62	-70.01
Net Income, 2 Yr. CAGR %	93.16	-52.81	206.89	584.49	-63.85
Normalized Net Income, 2 Yr. CAGR %	74.55	-34.84	182.57	357.54	-27.18
Diluted EPS Before Extra, 2 Yr. CAGR %	93.25	-52.86	206.86	584.63	-68.1
Accounts Receivable, 2 Yr. CAGR %	17.57	5.05	28	37.92	54.44
Inventory, 2 Yr. CAGR %	73.72	46.05	45.61	25.49	10.06
Net Property, Plant and Equip., 2 Yr. CAGR %	121.3	167.69	154.97	52.84	5.81
Total Assets, 2 Yr. CAGR %	91.72	77.41	75.93	43.23	11.62
Tangible Book Value, 2 Yr. CAGR %	39.43	40.79	44.15	46.08	42.63
Common Equity, 2 Yr. CAGR %	37.72	40.62	47.88	43.05	36.5
Cash From Operations, 2 Yr. CAGR %	455.47	386.14	-41.31	-35.09	-35.92
Capital Expenditures, 2 Yr. CAGR %	274.02	245.15	-4.53	-52.37	35.84
Levered Free Cash Flow, 2 Yr. CAGR %	151.96	170.75	-40.69	-58.71	68.81
Unlevered Free Cash Flow, 2 Yr. CAGR %	176.39	195.76	-4.2	-65.54	152.24
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	81.15	51.58	61.12	41.55	30.12
Gross Profit, 3 Yr. CAGR %	59.65	50.98	64.69	73.6	42.38
EBITDA, 3 Yr. CAGR %	113.72	38.61	35.6	52.31	42.01
EBITA, 3 Yr. CAGR %	131.46	39.31	30.41	48.32	42.99
EBIT, 3 Yr. CAGR %	137.74	41.05	31.53	51.33	47.91
Earnings From Cont. Operations, 3 Yr. CAGR %	20.25	-2.31	146.05	172.9	62.74
Net Income, 3 Yr. CAGR %	21.27	1.02	145.43	174.56	82.39
Normalized Net Income, 3 Yr. CAGR %	27.78	30.17	107.23	188.87	119.45
Diluted EPS Before Extra, 3 Yr. CAGR %	21.22	1.01	145.42	174.54	67.81
Accounts Receivable, 3 Yr. CAGR %	49.84	23	37.79	59.97	58.13
Inventory, 3 Yr. CAGR %	67.33	59.85	86.71	50.48	37.24
Net Property, Plant and Equip., 3 Yr. CAGR %	138.13	137.41	221.43	116.9	53.67
Total Assets, 3 Yr. CAGR %	83.45	79.93	128.78	73.23	49.1
Tangible Book Value, 3 Yr. CAGR %	50.62	54.38	61.85	86.21	44.9
Common Equity, 3 Yr. CAGR %	48.48	53.48	64.1	84.06	42.8
Cash From Operations, 3 Yr. CAGR %	173.68	228.39	139.97	-8.22	-48.1
Capital Expenditures, 3 Yr. CAGR %	179.03	160.43	155.86	-22.92	21.96
Levered Free Cash Flow, 3 Yr. CAGR %	59.02	202.22	24.97	-8.13	16.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	53.77	236.53	80.34	-17.32	12.43
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	80.97	63.28	69.43	76.87	68.5
Gross Profit, 5 Yr. CAGR %	60.92	62.4	74.98	81.16	76.76
EBITDA, 5 Yr. CAGR %	58.7	68.12	90.82	70.97	66.44
EBITA, 5 Yr. CAGR %	57.56	69.94	95.13	69.78	65.77
EBIT, 5 Yr. CAGR %	57.56	72.31	98.3	71.06	66.62
Earnings From Cont. Operations, 5 Yr. CAGR %	44.7	26.75	99.48	168.4	23.88
Net Income, 5 Yr. CAGR %	44.22	27.39	100.89	172.56	33.29
Normalized Net Income, 5 Yr. CAGR %	35.11	36.67	99.57	168.51	68.45
Diluted EPS Before Extra, 5 Yr. CAGR %	16.05	19.76	100.86	172.65	26.78
Accounts Receivable, 5 Yr. CAGR %	48.56	47.79	60.76	61.61	68.51
Inventory, 5 Yr. CAGR %	82.33	61.19	80.86	82.11	76.59
Net Property, Plant and Equip., 5 Yr. CAGR %	167.43	140.67	179.64	149.84	140.8
Total Assets, 5 Yr. CAGR %	97.22	73.67	106.14	106.13	100.61
Tangible Book Value, 5 Yr. CAGR %	109.18	52.01	69.11	89.52	79.78
Common Equity, 5 Yr. CAGR %	103.92	51.76	69.38	87.28	78.12
Cash From Operations, 5 Yr. CAGR %	299.46	228.66	68.93	115.49	59.4
Capital Expenditures, 5 Yr. CAGR %	245	144.41	107.61	65.66	132.07
Levered Free Cash Flow, 5 Yr. CAGR %	129.7	126.64	36.01	74.54	109.07
Unlevered Free Cash Flow, 5 Yr. CAGR %	175.49	136.96	64.82	73.53	112.38